Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Cytoplasmic RNA quality control failure engages mTORC1-mediated autoinflammatory disease
Kun Yang, Jie Han, Mayumi Asada, Jennifer G. Gill, Jason Y. Park, Meghana N. Sathe, Jyothsna Gattineni, Tracey Wright, Christian A. Wysocki, M. Teresa de la Morena, Luis A. Garza, Nan Yan
Kun Yang, Jie Han, Mayumi Asada, Jennifer G. Gill, Jason Y. Park, Meghana N. Sathe, Jyothsna Gattineni, Tracey Wright, Christian A. Wysocki, M. Teresa de la Morena, Luis A. Garza, Nan Yan
View: Text | PDF
Research Article Autoimmunity Metabolism

Cytoplasmic RNA quality control failure engages mTORC1-mediated autoinflammatory disease

  • Text
  • PDF
Abstract

Inborn errors of nucleic acid metabolism often cause aberrant activation of nucleic acid sensing pathways, leading to autoimmune or autoinflammatory diseases. The SKIV2L RNA exosome is cytoplasmic RNA degradation machinery that was thought to be essential for preventing the self-RNA–mediated interferon (IFN) response. Here, we demonstrate the physiological function of SKIV2L in mammals. We found that Skiv2l deficiency in mice disrupted epidermal and T cell homeostasis in a cell-intrinsic manner independently of IFN. Skiv2l-deficient mice developed skin inflammation and hair abnormality, which were also observed in a SKIV2L-deficient patient. Epidermis-specific deletion of Skiv2l caused hyperproliferation of keratinocytes and disrupted epidermal stratification, leading to impaired skin barrier with no appreciable IFN activation. Moreover, Skiv2l-deficient T cells were chronically hyperactivated and these T cells attacked lesional skin as well as hair follicles. Mechanistically, SKIV2L loss activated the mTORC1 pathway in both keratinocytes and T cells. Both systemic and topical rapamycin treatment of Skiv2l-deficient mice ameliorated epidermal hyperplasia and skin inflammation. Together, we demonstrate that mTORC1, a classical nutrient sensor, also senses cytoplasmic RNA quality control failure and drives autoinflammatory disease. We also propose SKIV2L-associated trichohepatoenteric syndrome (THES) as a new mTORopathy for which sirolimus may be a promising therapy.

Authors

Kun Yang, Jie Han, Mayumi Asada, Jennifer G. Gill, Jason Y. Park, Meghana N. Sathe, Jyothsna Gattineni, Tracey Wright, Christian A. Wysocki, M. Teresa de la Morena, Luis A. Garza, Nan Yan

×

Figure 3

Epidermal hyperproliferation in germline keratinocyte-specific Skiv2l knockout mice.

Options: View larger image (or click on image) Download as PowerPoint
Epidermal hyperproliferation in germline keratinocyte-specific Skiv2l kn...
(A) Western blot analysis of SKIV2L protein in epidermis isolated from Skiv2lctl and Skiv2lfl/flK14-Cre (germline keratinocyte-specific Skiv2l knockout) P0 pups. n = 3 per genotype. Skiv2lctl includes Skiv2lfl/fl, Skiv2lfl/+, and Skiv2lfl/+K14-Cre and all 3 genotypes showed no phenotypic difference (see Methods). (B) A summary of newborn genotypes from genetic crossing of Skiv2lfl/fl and Skiv2lfl/+K14-Cre mice. Asterisk indicates all Skiv2lfl/flK14-Cre newborns died within 24 hours after birth. (C and D) Skin appearance and whiskers of Skiv2lctl and Skiv2lfl/flK14-Cre P0 pups. (E) H&E staining of Skiv2lctl and Skiv2lfl/flK14-Cre P0 pup skin. Scale bar: 100 μm. (F) Fluorescence immunohistochemistry analysis of proliferation marker Ki67 in Skiv2lctl and Skiv2lfl/flK14-Cre P0 pup skin tissues. White arrows, Ki67-positive cells. Dashed line, epidermal-dermal junction. Scale bar: 20 μm. (G) Cell-cycle analysis of keratinocytes of Skiv2lctl and Skiv2lfl/flK14-Cre P0 pups. Statistics of cell cycle distributions are shown on the right. n = 4 pups per genotype. Unpaired 2-sided Student’s t test, ***P < 0.001. (H) Fluorescence immunohistochemistry analysis of K14, K5, and K10 in Skiv2lctl and Skiv2lfl/flK14-Cre P0 pup skin tissues. Dashed line, epidermal-dermal junction. Scale bar, 20 μm. (I) Representative Toluidine blue staining of Skiv2lctl and Skiv2lfl/flK14-Cre P0 pups.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts